Učitavanje...
Cenerimod, a novel selective S1P(1) receptor modulator with unique signaling properties
Sphingosine‐1‐phosphate receptor 1 (S1P(1)) modulators sequester circulating lymphocytes within lymph nodes, thereby preventing potentially pathogenic autoimmune cells from exiting into the blood stream and reaching inflamed tissues. S1P(1) receptor modulation may thus offer potential to treat vario...
Spremljeno u:
| Izdano u: | Pharmacol Res Perspect |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5723703/ https://ncbi.nlm.nih.gov/pubmed/29226621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.370 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|